characteristics: ERC000011
characteristics: ENA-CHECKLIST
characteristics: 2022-10-31T00:16:52Z
characteristics: ENA-FIRST-PUBLIC
characteristics: 2022-10-31T00:16:52Z
characteristics: ENA-LAST-UPDATE
characteristics: SAMEA111455297
characteristics: External Id
characteristics: Cancer Institute University College London
characteristics: INSDC center name
characteristics: 2022-10-31T00:16:52Z
characteristics: INSDC first public
characteristics: 2022-10-31T00:16:52Z
characteristics: INSDC last update
characteristics: public
characteristics: INSDC status
characteristics: ERS13549334
characteristics: SRA accession
characteristics: E-MTAB-12207:TA_K27ac_R2
characteristics: Submitter Id
characteristics: ArrayExpress
characteristics: broker name
characteristics: NALM6
characteristics: cell_line
characteristics: B-lymphoblast
characteristics: cell_type
characteristics: human
characteristics: common name
characteristics: Protocols: Cells were sorted to high purity for transgene expression (GFP), expanded in vitro, and approximately 10^8 cells harvested for subsequent ChIP experiments. Cells were crosslinked with 1% formaldehyde and sonicated to yield chromatin of 100-500 bp. ChIP was performed by as previously described (May et al., 2013) using antibodies: H3K27ac. See May et al, 2013. https://doi.org/10.1016/j.stem.2013.09.003
characteristics: description
characteristics: B-cell acute lymphoblastic leukemia
characteristics: disease
characteristics: ETV6-RUNX1
characteristics: genotype
characteristics: Homo sapiens
characteristics: organism
characteristics: Homo sapiens
characteristics: organism
characteristics: blood
characteristics: organism part
characteristics: induced pluripotent stem cell
characteristics: progenitor cell type
characteristics: Homo sapiens
characteristics: scientific_name
characteristics: TA_K27ac_R2
characteristics: title